Companies: 49,247 Total Market Cap: 132635406794329.84

LabGenomics

KOSDAQ-084650

Commercial Physical and Biological Research

Rank #22173

Market Cap 133.16 M

Volume 15.77 M

Price 1.90

Change (%) 6.19%

Country or region

South Korea

LabGenomics's latest marketcap:

133.16 M

As of 05/21/2025, LabGenomics's market capitalization has reached $133.16 M. According to our data, LabGenomics is the 22173th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	133.16 M
Revenue (ttm)	61.50 M
Net Income (ttm)	-17,037,920.17
Shares Out	74.24 M
EPS (ttm)	-0.23
Forward PE	0.00
Ex-Dividend Date	n/a
Earnings Date	05/15/2025

Market Cap Chart

Data Updated: 05/21/2025

LabGenomics's yearly market capitalization.

LabGenomics has seen its market value drop from ₩213.66 B to ₩185.97 B since 2020, representing a total decrease of 12.96% and an annual compound decline rate (CAGR) of 3.11%.

Date	Market Cap	Change (%)
05/21/2025	₩185.97 B	-13.86%
12/30/2024	₩184.86 B	-35.41%
12/28/2023	₩286.20 B	33.64%
12/29/2022	₩214.15 B	-23.76%
12/30/2021	₩280.90 B	31.47%
12/30/2020	₩213.66 B

Company Profile

About LabGenomics Co., Ltd.

LabGenomics Co., Ltd. is a biotechnology company specializing in the research, development, and commercialization of innovative diagnostic solutions. Headquartered in Seongnam-si, South Korea, the company has been at the forefront of medical advancements since its founding in 2002.

Core Activities

Biotechnology R&D: Focused on pioneering research to develop cutting-edge diagnostic technologies.
Diagnostic Devices: Engaged in the manufacturing and distribution of high-quality diagnostic equipment.

Company Overview

LabGenomics combines scientific expertise with a commitment to improving healthcare outcomes. Its products and innovations contribute to the global medical community, enhancing diagnostic accuracy and efficiency.

Frequently Asked Questions

As of 05/21/2025, LabGenomics (including the parent company, if applicable) has an estimated market capitalization of $133.16 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

LabGenomics global market capitalization ranking is approximately 22173 as of 05/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	South Korea
Founded	2002
IPO Date	n/a
Employees	170
CEO	Sung Chin
Sector
Industry	Commercial Physical and Biological Research
Address	Korea Bio Park B-dong Seongnam-si, 463-400 South Korea
Website	https://www.labgenomics.co.kr